Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Y. Shanti Prabha, Dr. V S Krishna Government Degree and PG College, India.
(2) Komaragiri Krishna, Vignan’s Foundation for Science, Technology, and Research, India.
Additional Reviewers:
(1) RLC.Sasidhar, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.25/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Y. Shanti Prabha, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Komaragiri Krishna, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA